AC Immune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

CEO

Andrea Pfeifer

CEOAndrea Pfeifer

Employees

172

Employees172

Headquarters

Lausanne, Vaud

HeadquartersLausanne, Vaud

Founded

2003

Founded2003

Employees

172

Employees172

ACIU Key Statistics

Market cap

160.78M

Market cap160.78M

Price-Earnings ratio

-2.79

Price-Earnings ratio-2.79

Dividend yield

—

Dividend yield—

Average volume

151.09K

Average volume151.09K

High today

$1.73

High today$1.73

Low today

$1.61

Low today$1.61

Open price

$1.70

Open price$1.70

Volume

95.60K

Volume95.60K

52 Week high

$4.98

52 Week high$4.98

52 Week low

$1.43

52 Week low$1.43

ACIU News

TipRanks 20h

AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating

Leerink Partners analyst Marc Goodman maintained a Buy rating on AC Immune SA (ACIU – Research Report) on May 2 and set a price target of $9.00. Marc Goodman h...

People also own

Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.